cemiplimab Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (2)

Interventional (3)

Emory University (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
Vyriad, Inc. (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadoophorectomy

I am/have/hadmajor surgery

I am/have/hadseizure

I am/have/hadsquamous cell carcinoma

I am/have/hadmetastasis

I am/have/hadhypothyroidism

I am/have/hadhair thinning

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadcancer

I am/have/hadnon-small cell lung cancer

I am/have/hadadenocarcinoma

I am/have/hadcarcinoma

I am/have/hadextranodal extension

I am/have/hadhormone replacement therapy

I am/have/hadmonoclonal antibody therapy

I am/have/hadantiviral therapy

I am/have/hadcancer therapy

I am/have/hadmeasurable disease

I am/have/hadacquired immunodeficiency syndrome (aids)

I am/have/hadhepatitis

added new label for I am/have/had

I am looking for

I am looking foripilimumab

I am looking forfollicle stimulating hormone

I am looking forantiviral drugs

I am looking forsorafenib

I am looking forhepatitis b surface antigen

I am looking forimmune checkpoint inhibitor

I am looking forprednisone

I am looking formelanoma

I am looking formonoclonal antibodies

I am looking forheparin

I am looking forcemiplimab

I am looking forhepatitis b antigen

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

The purpose of this research study is to determine how people with weakened immune systems and unresectable (cannot be removed by surgery) locally recurrent and/or metastatic cutaneous squamous cell carcinoma (CSCC) respond to study treatment with Cemiplimab. Cemiplimab is approved for sale in United States by the U.S. Food and …

lymphoma

squamous cell carcinoma

squamous cell carcinoma of the skin

metastasis

cancer

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Dermatology
Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

hepatitis

seizure

metastasis

antiviral drugs

hepatitis b surface antigen

0 views
16 Feb, 2024
9 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

Giving cemiplimab before surgery may improve risk of the cancer returning in patients with high risk cutaneous squamous cell cancer.

oophorectomy

neuropathy

major surgery

primary lesion

squamous cell carcinoma

0 views
05 Aug, 2020